James C. Lee

761 total citations
26 papers, 360 citations indexed

About

James C. Lee is a scholar working on Cardiology and Cardiovascular Medicine, Pharmacology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, James C. Lee has authored 26 papers receiving a total of 360 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cardiology and Cardiovascular Medicine, 8 papers in Pharmacology and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in James C. Lee's work include Pharmacogenetics and Drug Metabolism (7 papers), Atrial Fibrillation Management and Outcomes (6 papers) and Pharmaceutical studies and practices (5 papers). James C. Lee is often cited by papers focused on Pharmacogenetics and Drug Metabolism (7 papers), Atrial Fibrillation Management and Outcomes (6 papers) and Pharmaceutical studies and practices (5 papers). James C. Lee collaborates with scholars based in United States, Taiwan and Japan. James C. Lee's co-authors include Edith A. Nutescu, Wei‐Han Cheng, Beenish S. Manzoor, Kazuhiko Kido, Sang Joon Ahn, Irena Levitan, Shubha Bhat, Michael P. Gulseth, Ibra S. Fancher and Stephanie A. Flowers and has published in prestigious journals such as PLoS ONE, Scientific Reports and Arteriosclerosis Thrombosis and Vascular Biology.

In The Last Decade

James C. Lee

24 papers receiving 350 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James C. Lee United States 12 137 68 54 52 44 26 360
Ariola Koci Italy 10 111 0.8× 51 0.8× 60 1.1× 19 0.4× 14 0.3× 16 386
Glynn Morrish Australia 6 33 0.2× 73 1.1× 43 0.8× 14 0.3× 12 0.3× 12 351
Alan Yean Yip Fong Malaysia 15 350 2.6× 131 1.9× 26 0.5× 35 0.7× 10 0.2× 78 659
Rachida Habbal Morocco 12 182 1.3× 44 0.6× 26 0.5× 13 0.3× 8 0.2× 121 415
Valérie Gras France 11 35 0.3× 57 0.8× 32 0.6× 6 0.1× 56 1.3× 29 371
J. Dolben United Kingdom 10 156 1.1× 44 0.6× 45 0.8× 79 1.5× 7 0.2× 18 509
B. H. Ch. Stricker Netherlands 10 194 1.4× 81 1.2× 137 2.5× 23 0.4× 6 0.1× 16 551
Michael Ward Australia 11 107 0.8× 41 0.6× 80 1.5× 13 0.3× 23 0.5× 50 436
Shu‐Chen Chien Taiwan 11 63 0.5× 62 0.9× 37 0.7× 13 0.3× 6 0.1× 25 380
Natsumi Ueda Japan 13 59 0.4× 37 0.5× 80 1.5× 12 0.2× 24 0.5× 24 468

Countries citing papers authored by James C. Lee

Since Specialization
Citations

This map shows the geographic impact of James C. Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James C. Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James C. Lee more than expected).

Fields of papers citing papers by James C. Lee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James C. Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James C. Lee. The network helps show where James C. Lee may publish in the future.

Co-authorship network of co-authors of James C. Lee

This figure shows the co-authorship network connecting the top 25 collaborators of James C. Lee. A scholar is included among the top collaborators of James C. Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James C. Lee. James C. Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
O’Leary, Kevin J., Edith A. Nutescu, Tai C. Chen, et al.. (2025). Results of the ACCOuNT Trial: A Multi‐Institutional Prospective Pharmacogenomics Implementation Trial for African American Inpatients. Clinical Pharmacology & Therapeutics. 119(1). 109–119. 1 indexed citations
2.
3.
Kim, Kibum, Julio D. Duarte, William Galanter, et al.. (2023). Pharmacist-Guided Pharmacogenetic Service Lowered Warfarin-Related Hospitalizations. Pharmacogenomics. 24(6). 303–314. 2 indexed citations
4.
5.
Wake, Dyson T., et al.. (2022). Pharmacogenomics of Medications Given Via Nonconventional Administration Routes: A Scoping Review. Pharmacogenomics. 23(17). 933–948. 1 indexed citations
6.
Frisoli, Tiberio, Marvin H. Eng, Pedro Engel Gonzalez, et al.. (2022). Percutaneous Aspiration Thrombectomy of Thrombus Attached to Left Atrial Surface of a Watchman FLX Device. JACC. Clinical electrophysiology. 8(2). 277–279. 10 indexed citations
7.
Aguilar, Víctor, et al.. (2022). Caveolin-1 is a primary determinant of endothelial stiffening associated with dyslipidemia, disturbed flow, and ageing. Scientific Reports. 12(1). 17822–17822. 15 indexed citations
8.
Kido, Kazuhiko, Douglas Slain, Khalid M. Kamal, & James C. Lee. (2022). Adapting the layered learning model to a virtual international exchange program. Currents in Pharmacy Teaching and Learning. 14(12). 1500–1505. 1 indexed citations
9.
Kim, Kibum, James C. Lee, Jin Han, et al.. (2022). Changing from Mandatory to Optional Genotyping Results in Higher Acceptance of Pharmacist-Guided Warfarin Dosing. Pharmacogenomics. 23(2). 85–95. 1 indexed citations
10.
Marottoli, Felecia M., Troy N. Trevino, Xue Geng, et al.. (2021). Autocrine Effects of Brain Endothelial Cell-Produced Human Apolipoprotein E on Metabolism and Inflammation in vitro. Frontiers in Cell and Developmental Biology. 9. 668296–668296. 18 indexed citations
11.
Kido, Kazuhiko, James C. Lee, Christopher Bianco, et al.. (2021). Meta-analysis comparing direct oral anticoagulants versus vitamin K antagonists in patients with left ventricular thrombus. PLoS ONE. 16(6). e0252549–e0252549. 14 indexed citations
12.
Fancher, Ibra S., Sang Joon Ahn, James C. Lee, et al.. (2020). Impairment of Flow-Sensitive Inwardly Rectifying K + Channels via Disruption of Glycocalyx Mediates Obesity-Induced Endothelial Dysfunction. Arteriosclerosis Thrombosis and Vascular Biology. 40(9). e240–e255. 35 indexed citations
13.
Flowers, Stephanie A., Shubha Bhat, & James C. Lee. (2020). Potential Implications of Gut Microbiota in Drug Pharmacokinetics and Bioavailability. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 40(7). 704–712. 22 indexed citations
14.
Hicks, J. Kevin, Christina L. Aquilante, Henry M. Dunnenberger, et al.. (2019). Precision pharmacotherapy: Integrating pharmacogenomics into clinical pharmacy practice. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 2(3). 303–313. 54 indexed citations
15.
Wang, Dee Dee, Thomas J. Forbes, James C. Lee, & Marvin H. Eng. (2018). Echocardiographic Imaging for Left Atrial Appendage Occlusion. Interventional Cardiology Clinics. 7(2). 219–228. 7 indexed citations
16.
Lee, James C., et al.. (2018). Prolonged Effects of Elevated 17β-Estradiol on Physical Activity after Orchidectomy. Medicine & Science in Sports & Exercise. 50(8). 1588–1595. 2 indexed citations
17.
Phillips, Jennifer, et al.. (2018). Best practices: Incorporating pharmacy technicians and other support personnel into the clinical pharmacist's process of care. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 2(1). 74–81. 16 indexed citations
18.
Lee, James C., et al.. (2017). Clinical Effect of CYP2C9*5/*6 Genotype on a Patient’s Warfarin Dose Requirement. Pharmacogenomics. 18(11). 1051–1057. 6 indexed citations
19.
Lee, James C., et al.. (2017). Clinical and Financial Outcomes Evaluation of Multimodal Pharmacist Warfarin Management of a Statewide Urban and Rural Population. Journal of Pharmacy Practice. 31(2). 150–156. 10 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ariola Koci Breakdown of academic impact, for papers by Glynn Morrish Breakdown of academic impact, for papers by Alan Yean Yip Fong Breakdown of academic impact, for papers by Rachida Habbal Breakdown of academic impact, for papers by Valérie Gras Breakdown of academic impact, for papers by J. Dolben Breakdown of academic impact, for papers by B. H. Ch. Stricker Breakdown of academic impact, for papers by Michael Ward Breakdown of academic impact, for papers by Shu‐Chen Chien Breakdown of academic impact, for papers by Natsumi Ueda
Rankless by CCL
2026